Press "Enter" to skip to content

New patent for Galderma Labs drug SOOLANTRA

0
Copyright © DrugPatentWatch. Originally published at New patent for Galderma Labs drug SOOLANTRA

Annual Drug Patent Expirations for SOOLANTRA
Annual Drug Patent Expirations for SOOLANTRA

Soolantra is a drug marketed by Galderma Labs Lp and is included in one NDA. It is available from three suppliers. There are eleven patents protecting this drug and one Paragraph IV challenge.

SOOLANTRA drug price trends.

Drug patent litigation for SOOLANTRA.

This drug has seventy-one patent family members in twenty-eight countries.

The generic ingredient in SOOLANTRA is ivermectin. Three suppliers are listed for this compound. Additional details are available on the ivermectin profile page.

For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact admin@DrugPatentWatch.com or visit www.DrugPatentWatch.com

Make Better Decisions with DrugPatentWatch

» Start Your Free Trial Today «

Copyright © DrugPatentWatch. Originally published at New patent for Galderma Labs drug SOOLANTRA
Find your next blockbuster

Get accurate and timely intelligence — in just a few clicks

✓ Free trial

✓ No credit card

 

DrugPatentWatch - Make Better Decisions